Ingevity Corp (NGVT) Given “Buy” Rating at KeyCorp

KeyCorp reissued their buy rating on shares of Ingevity Corp (NASDAQ:NGVT) in a report released on Thursday morning. The brokerage currently has a $75.00 price objective on the stock, up from their prior price objective of $70.00. KeyCorp also issued estimates for Ingevity Corp’s FY2018 earnings at $2.80 EPS.

Other equities research analysts also recently issued reports about the company. Jefferies Group LLC set a $68.00 price target on Ingevity Corp and gave the company a buy rating in a research note on Wednesday, July 19th. BidaskClub downgraded Ingevity Corp from a sell rating to a strong sell rating in a research note on Friday, September 15th. Zacks Investment Research downgraded Ingevity Corp from a hold rating to a sell rating in a research note on Wednesday, August 2nd. Aegis restated a buy rating and set a $67.00 price target on shares of Ingevity Corp in a research note on Tuesday, July 4th. Finally, Loop Capital began coverage on Ingevity Corp in a research note on Thursday, September 28th. They set a buy rating and a $73.00 price target for the company. One research analyst has rated the stock with a sell rating and six have given a buy rating to the company’s stock. Ingevity Corp currently has a consensus rating of Buy and an average target price of $69.83.

Shares of Ingevity Corp (NASDAQ:NGVT) opened at 65.67 on Thursday. The stock has a market capitalization of $2.77 billion and a P/E ratio of 52.45. Ingevity Corp has a 12-month low of $40.24 and a 12-month high of $66.01. The firm’s 50-day moving average is $61.74 and its 200 day moving average is $61.74.

Ingevity Corp (NASDAQ:NGVT) last released its quarterly earnings results on Wednesday, August 2nd. The company reported $0.78 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.70 by $0.08. The business had revenue of $260.30 million during the quarter, compared to the consensus estimate of $259.56 million. Ingevity Corp had a return on equity of 76.78% and a net margin of 13.75%. Ingevity Corp’s quarterly revenue was up 2.3% on a year-over-year basis. On average, equities research analysts forecast that Ingevity Corp will post $2.41 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Ingevity Corp (NGVT) Given “Buy” Rating at KeyCorp” was first published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this piece of content on another website, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece of content can be read at https://ledgergazette.com/2017/10/09/ingevity-corp-ngvt-given-buy-rating-at-keycorp.html.

Large investors have recently made changes to their positions in the stock. Pacad Investment Ltd. bought a new position in shares of Ingevity Corp during the 2nd quarter valued at approximately $183,000. Envestnet Asset Management Inc. grew its stake in shares of Ingevity Corp by 46.9% during the 1st quarter. Envestnet Asset Management Inc. now owns 3,500 shares of the company’s stock valued at $211,000 after acquiring an additional 1,117 shares during the period. Cubist Systematic Strategies LLC bought a new position in shares of Ingevity Corp during the 2nd quarter valued at approximately $203,000. Balyasny Asset Management LLC bought a new position in shares of Ingevity Corp during the 2nd quarter valued at approximately $213,000. Finally, Los Angeles Capital Management & Equity Research Inc. grew its stake in shares of Ingevity

Other equities research analysts also recently issued reports about the company. Jefferies Group LLC set a $68.00 price target on Ingevity Corp and gave the company a buy rating in a research note on Wednesday, July 19th. BidaskClub downgraded Ingevity Corp from a sell rating to a strong sell rating in a research note on Friday, September 15th. Zacks Investment Research downgraded Ingevity Corp from a hold rating to a sell rating in a research note on Wednesday, August 2nd. Aegis restated a buy rating and set a $67.00 price target on shares of Ingevity Corp in a research note on Tuesday, July 4th. Finally, Loop Capital began coverage on Ingevity Corp in a research note on Thursday, September 28th. They set a buy rating and a $73.00 price target for the company. One research analyst has rated the stock with a sell rating and six have given a buy rating to the company’s stock. Ingevity Corp currently has a consensus rating of Buy and an average target price of $69.83.

Shares of Ingevity Corp (NASDAQ:NGVT) opened at 65.67 on Thursday. The stock has a market capitalization of $2.77 billion and a P/E ratio of 52.45. Ingevity Corp has a 12-month low of $40.24 and a 12-month high of $66.01. The firm’s 50-day moving average is $61.74 and its 200 day moving average is $61.74.

Ingevity Corp (NASDAQ:NGVT) last released its quarterly earnings results on Wednesday, August 2nd. The company reported $0.78 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.70 by $0.08. The business had revenue of $260.30 million during the quarter, compared to the consensus estimate of $259.56 million. Ingevity Corp had a return on equity of 76.78% and a net margin of 13.75%. Ingevity Corp’s quarterly revenue was up 2.3% on a year-over-year basis. On average, equities research analysts forecast that Ingevity Corp will post $2.41 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Ingevity Corp (NGVT) Given “Buy” Rating at KeyCorp” was first published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this piece of content on another website, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece of content can be read at https://ledgergazette.com/2017/10/09/ingevity-corp-ngvt-given-buy-rating-at-keycorp.html.

Large investors have recently made changes to their positions in the stock. Pacad Investment Ltd. bought a new position in shares of Ingevity Corp during the 2nd quarter valued at approximately $183,000. Envestnet Asset Management Inc. grew its stake in shares of Ingevity Corp by 46.9% during the 1st quarter. Envestnet Asset Management Inc. now owns 3,500 shares of the company’s stock valued at $211,000 after acquiring an additional 1,117 shares during the period. Cubist Systematic Strategies LLC bought a new position in shares of Ingevity Corp during the 2nd quarter valued at approximately $203,000. Balyasny Asset Management LLC bought a new position in shares of Ingevity Corp during the 2nd quarter valued at approximately $213,000. Finally, Los Angeles Capital Management & Equity Research Inc. grew its stake in shares of Ingevity Corp by 5.4% during the 2nd quarter. Los Angeles Capital Management & Equity Research Inc. now owns 4,072 shares of the company’s stock valued at $234,000 after acquiring an additional 210 shares during the period.

Ingevity Corp Company Profile

Ingevity Corporation is a manufacturer of specialty chemicals and high performance carbon materials. The Company is also a manufacturer of activated carbon used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Company operates through two segments: Performance Materials and Performance Chemicals.

Analyst Recommendations for Ingevity Corp (NASDAQ:NGVT)

Receive News & Ratings for Ingevity Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity Corp and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply